Stage 2 prostate cancer is considered localized, meaning the cancer is still confined entirely within the prostate gland and has not spread to nearby lymph nodes (node 0 or N0) or distant parts of the ...

After 23 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) confirmed a 13% lower ...

The market awaits Public Storage's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter. It's important for new invest ...

Objective To investigate the association between peripheral disease activity and pre-eclampsia, gestational hypertension, ...

Grape seed extract—a dietary supplement made from the seeds of wine grapes—has been investigated to see if it can help reduce ...

Morning, Collectors. It wasn’t that long ago where GameStop was considered a dying company, only in the news because a group ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

BERLIN — For men with high-risk biochemically recurrent prostate cancer, adding enzalutamide (Xtandi) to standard androgen ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, ...

On-treatment PSA and disease burden should be considered together for prognostication. Achieving PSA ≤0.2 ng/mL within 6–12 weeks strongly predicts favorable long-term survival. Metastatic volume and ...